Eiger BioPharmaceuticals to Participate in September Conferences

PALO ALTO, Calif. – August 29, 2019 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will participate in the following upcoming investor conferences in September:

• Baird 2019 Global Healthcare Conference at the InterContinental Barclay in New York City. Eiger will present a corporate update with a live webcast on September 4, 9:05-9:35 PM ET.  Eiger will host one-on-one meetings.
• CITI 14^th Annual Biotech Conference at the Four Seasons Hotel in Boston on September 5. Eiger will host one-on-one meetings.
• C. Wainwright Global Investment Conference at the Lotte New York Hotel in New York City. Eiger will present a corporate update with a live webcast on  September 10, 3:00-3:25 PM ET.  Eiger will host one-on-one meetings.
• Ladenburg Thalmann 2019 Healthcare Conference at Sofitel Hotel in New York City. Eiger will present a corporate update with a live webcast on September 24, 12:00-12:25 PM ET.  Eiger will host one-on-one meetings.

The live webcast of the Baird, H.C. Wainwright, and Ladenburg presentations will be available on the Eiger BioPharmaceuticals website at www.eigerbio.com under the “Investors” tab.  A replay of the webcast will be available approximately one hour following the live event.